Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Liqiu Kou"'
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-12 (2023)
Abstract Objective To systematically evaluate the efficacy and safety of FDA-approved isocitrate dehydrogenase (IDH) inhibitors in the treatment of IDH-mutated acute myeloid leukemia (AML). Methods We used R software to conduct a meta-analysis of pro
Externí odkaz:
https://doaj.org/article/1fb8418815594aef803ff55a77292a12
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-17 (2023)
Abstract Objective To analyze the incidence and risk of hypertension associated with poly(adenosine diphosphate-ribose) polymerase (PARP) inhibitors in cancer patients and provide reference for clinicians. Methods We used R software to conduct a meta
Externí odkaz:
https://doaj.org/article/86914e169bc7493c86bafa1637eb4f40
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveTo study the incidence and distribution of adverse events in immune checkpoint inhibitors (ICI) for digestive system cancers and to provide a reference for the safe, rational, and effective use of immune detection site inhibitors.MethodsWe s
Externí odkaz:
https://doaj.org/article/137a807e94e448d4bf817138bbf12d03
Publikováno v:
Frontiers in Aging Neuroscience, Vol 14 (2022)
BackgroundNilotinib, which inhibits cellular Abelson tyrosine kinase, may be an effective treatment for patients with Parkinson's disease (PD). The purpose of this study is to evaluate the outcomes of different doses of nilotinib in patients with PD.
Externí odkaz:
https://doaj.org/article/5c3eb298507e4512992f38113157b734
Publikováno v:
Reviews in Medical Virology.
Publikováno v:
Japanese Journal of Clinical Oncology.
Objective We performed a meta-analysis to assess the efficacy and safety of T-DXd in the treatment of HER2-expressing solid tumours. Methods We systematically searched PubMed, Web of Science, Embase and the Cochrane Library and collected studies publ